![]() |
市场调查报告书
商品编码
1679304
2030 年甜菊糖配糖体市场预测:按类型、形式、来源、分销管道、应用和地区进行的全球分析Steviol Glycoside Market Forecasts to 2030 - Global Analysis By Type (Steviolbioside, Stevioside, Rebaudioside A and Other Types), Form, Source, Distribution Channel, Application and By Geography |
根据 Stratistics MRC 的数据,全球甜菊糖配糖体市场预计在 2024 年达到 56.7 亿美元,到 2030 年将达到 84.1 亿美元,预测期内的复合年增长率为 6.8%。
从甜菊叶中提取的天然甜味剂称为甜菊糖配糖体。这些配糖体(包括甜菊糖和莱鲍迪苷)使得甜菊糖的甜度比糖高 300 倍。由于其热量低,因此它是食品和饮料中常用的糖替代品。在体内,甜菊糖配糖体会转化为甜菊醇并排放,而不会增加血糖值。由于其耐用性和健康益处,它经常用于国际卫生当局核准的低热量和糖尿病产品。
对天然甜味剂的需求不断增加
对肥胖和糖尿病的认识不断增加,促使消费者转向更健康的糖替代品。食品和饮料製造商使用配糖体来满足消费者对植物来源、低热量甜味剂的需求。洁净标示趋势和监管部门的核准进一步推动了市场扩张。萃取技术的发展提高了最终产品的品质和价格。此外,该产品在个人护理和药物领域的广泛应用也刺激了市场扩张。
供应炼和原料依赖性
由于甜菊植物的生产来源有限,市场容易受到农业中断和气候变迁的影响。物流和运输问题增加了前置作业时间并影响供应稳定性。对特定地区原料供应的依赖增加了贸易限制和地缘政治不稳定的可能性。原物料价格的波动会影响公司的定价策略和盈利。总的来说,这些变数造成了不确定性,限制了市场成长和投资者信心。
对洁净标示和有机产品的需求不断增加
对肥胖和糖尿病的认识不断增加,促使消费者转向更健康的糖替代品。食品和饮料製造商使用配糖体来满足消费者对植物来源、低热量甜味剂的需求。洁净标示趋势和监管部门的核准进一步推动了市场扩张。萃取技术的发展提高了最终产品的品质和价格。此外,个人护理和医药产品的使用日益增多也刺激了市场扩张。
监管不确定性和严格标准
各国的核准程序不尽相同,减缓了新产品的推出和市场的成长。严格的安全和品质标准提高了生产成本,使中小企业难以竞争。可接受的配糖体组成的频繁变化会给生产者带来不稳定。冗长的核准流程不利于研发投资。因此,甜菊糖配糖体在食品饮料领域的广泛应用受到市场扩张放缓的限制。
COVID-19 的影响
COVID-19 疫情影响了供应链,减缓了生产速度,并减少了食品和饮料等行业的消费需求,扰乱了配糖体市场。停工和物流挑战影响了原料的可得性,增加了成本。然而,随着消费者转向更健康的天然甜味剂,疫情后需求已经反弹。人们对保健产品中糖替代品的认识不断提高,这也使市场受益。总体而言,虽然早期的干扰已经减缓了成长,但由于人们健康意识的增强和对洁净标示产品的偏好,长期前景仍然光明。
预计粉末市场在预测期内将占据最大份额
由于粉末具有高稳定性、长保质期以及易于加入各种食品和饮料产品的特点,预计在预测期内将占据最大的市场占有率。它广泛用于製药和营养保健食品行业的无糖配方。消费者对低热量和天然甜味剂的偏好增加,推动了需求。此外,其成本效益和高效的运输能力使其成为製造商的首选。不断增强的健康意识和监管部门的核准进一步推动了市场的成长。
预计预测期内,製药业将以最高的复合年增长率成长。
由于药用糖浆、锭剂和保健品中对天然低热量甜味剂的需求很高,预计预测期内製药业将出现最高成长率。由于其不产碱且适合糖尿病患者,因此成为药物製剂中首选的糖替代品。消费者对健康益处的认识不断提高以及监管部门的核准进一步推动了它们在药物配方中的应用。药品向植物来源成分的转变将推动市场成长。此外,对甜菊糖配糖体潜在治疗效果的持续研究也加强了其在该领域的应用。
在预测期内,由于对天然低热量甜味剂的需求不断增加,预计北美将占据最大的市场占有率。糖尿病和肥胖症的盛行率不断上升,促使消费者转向糖替代品,从而推动食品和饮料中对甜菊糖製品的采用。美国和加拿大是主要市场,这两个国家的公司专注于产品创新和洁净标示运动。美国食品药物管理局(FDA)和加拿大卫生署的监管核准正在进一步加速市场扩张。主要企业包括嘉吉、宜瑞安和PureCircle,它们正在利用萃取技术的进步来提高其产品的品质和甜度。
预计预测期内亚太地区将呈现最高的复合年增长率。这是由于人们的健康意识不断增强以及对糖替代品的监管支持导致对天然甜味剂的需求不断增长。中国、印度和日本等国家是主要市场,在食品、饮料和药品领域的应用正在扩大。机能性食品和饮料产业的成长,加上消费者对低热量产品的偏好,正在推动需求。此外,提取技术的进步和大公司的投资也有助于推动市场扩张。该地区糖尿病患者的不断增长进一步增加了对甜菊糖甜味剂的需求。
According to Stratistics MRC, the Global Steviol Glycoside Market is accounted for $5.67 billion in 2024 and is expected to reach $8.41 billion by 2030 growing at a CAGR of 6.8% during the forecast period. Natural sweet substances called steviol glycosides are extracted from the leaves of the Stevia rebaudiana plant. Stevia is up to 300 times sweeter than sugar due to these glycosides, which also include stevioside and rebaudioside. They are a common sugar alternative in foods and drinks since they are low in calories. The body converts steviol glycosides into steviol, which is then eliminated without increasing blood sugar levels. Because of their durability and health advantages, they are frequently used in low-calorie and diabetic-friendly products that have been approved by international health authorities.
Rising demand for natural sweeteners
Growing knowledge of obesity and diabetes is causing consumers to turn to healthier sugar substitutes. Steviol glycosides are being used by food and beverage producers to satisfy consumer demand for plant-based, low-calorie sweeteners. Market expansion is further supported by clean-label trends and regulatory approvals. Technological developments in extraction improve the quality and affordability of the final product. Market expansion is also fuelled by the growing use of personal care and pharmaceutical goods.
Supply chain & raw material dependence
The market is susceptible to agricultural interruptions and climate change due to the limited sources of stevia plant production. Problems with logistics and transportation lengthen lead times, which impacts consistent supply. Reliance on certain areas for raw supplies increases the likelihood of trade restrictions and geopolitical unrest. Changes in raw material prices have an effect on firms' pricing strategies and profitability. All things considered, these variables provide uncertainty, which restricts market growth and investor confidence.
Growing demand for clean-label & organic products
Growing knowledge of obesity and diabetes is causing consumers to turn to healthier sugar substitutes. Steviol glycosides are being used by food and beverage producers to satisfy consumer demand for plant-based, low-calorie sweeteners. Market expansion is further supported by clean-label trends and regulatory approvals. Technological developments in extraction improve the quality and affordability of the final product. Market expansion is also fuelled by the growing use of personal care and pharmaceutical goods.
Regulatory uncertainty & stringent standards
Approval procedures differ per nation, which delays the introduction of new products and the growth of markets. Strict safety and quality standards raise production costs, which makes it harder for small businesses to compete. Producers experience instability as a result of frequent changes in the acceptable glycoside compositions. Investment in R&D is discouraged by lengthy approval processes. Steviol glycosides' broad use in the food and beverage sector is thus constrained by the slowing market expansion.
Covid-19 Impact
The COVID-19 pandemic disrupted the steviol glycoside market by affecting supply chains, delaying production, and reducing consumer demand in sectors like food and beverages. Lockdowns and logistical challenges impacted raw material availability, increasing costs. However, as consumers shifted towards healthier, natural sweeteners, demand rebounded post-pandemic. The market also benefited from increased awareness of sugar alternatives in wellness products. Overall, while initial disruptions slowed growth, the long-term outlook remains positive due to rising health consciousness and clean-label product preferences.
The powder segment is expected to be the largest during the forecast period
The powder segment is expected to account for the largest market share during the forecast period, due to its high stability, longer shelf life, and ease of incorporation into various food and beverage products. It is widely used in the pharmaceutical and nutraceutical industries for sugar-free formulations. The growing consumer preference for low-calorie and natural sweeteners boosts its demand. Additionally, its cost-effectiveness and efficient transportability make it a preferred choice for manufacturers. Increasing health consciousness and regulatory approvals further drive its market growth.
The pharmaceuticals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate, due to the high demand for natural, low-calorie sweeteners in medicinal syrups, tablets, and health supplements. Its non-cariogenic and diabetic-friendly properties make it a preferred sugar alternative in pharmaceutical formulations. Rising consumer awareness of health benefits and regulatory approvals further boost its adoption in drug formulations. The shift toward plant-based ingredients in pharmaceuticals enhances market growth. Additionally, ongoing research into steviol glycosides' potential therapeutic benefits strengthens their application in the sector.
During the forecast period, the North America region is expected to hold the largest market share due to increasing demand for natural, low-calorie sweeteners. The rising prevalence of diabetes and obesity has driven consumers toward sugar alternatives, boosting the adoption of stevia-based products in food and beverages. The U.S. and Canada are key markets, with companies focusing on product innovation and clean-label trends. Regulatory approvals from the FDA and Health Canada have further accelerated market expansion. Key players include Cargill, Ingredion, and PureCircle, leveraging advancements in extraction techniques to enhance product quality and sweetness profiles.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rising demand for natural sweeteners, driven by increasing health consciousness and regulatory support for sugar alternatives. Countries like China, India, and Japan are key markets, with expanding applications in food, beverages, and pharmaceuticals. The growth of the functional food and beverage sector, coupled with consumer preference for low-calorie products, is fueling demand. Additionally, advancements in extraction technologies and investments by major players are boosting market expansion. The region's flourishing diabetic population further strengthens the need for stevia-based sweeteners.
Key players in the market
Some of the key players profiled in the Steviol Glycoside Market include Cargill, Incorporated, PureCircle Ltd., Tate & Lyle PLC, GLG Life Tech Corporation, Ingredion Incorporated, Sunwin Stevia International, Inc., Stevia Corp., Morita Kagaku Kogyo Co., Ltd., Zhucheng Haotian Pharm Co., Ltd., Daepyung Co., Ltd., Sunrise Nutrachem Group, Merisant, Evolva Holding SA, SweeGen, Inc., Blue California, Layn Corp., DSM and FUJIFILM Wako Pure Chemical Corporation.
In October 2024, Tate & Lyle announced a strategic partnership with Manus, a bioalternatives scale-up platform, to expand access to natural sugar reduction solutions. The collaboration focused on the large-scale commercialization of stevia Reb M, sourced and manufactured in the Americas.
In August 2024, Tate & Lyle introduced OPTIMISER STEVIA 8.10, a new stevia composition designed to provide a premium flavor profile even at high sugar replacement levels. This product offers a cost-effective and versatile solution for manufacturers seeking natural sweeteners.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.